Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 477 results for "cadila pharma"

Gujarat State TB Association, Sparsh with Cadila Pharma organi...

Awareness was raised on tuberculosis where more than 300 villagers underwent health checkups and were given consultations Cadila Pharmaceuticals in association with Gujarat State Tuberculosis Association and Sparsh Hospital recently organised a ... Financial Express, 1 week ago

Buy Cadila Healthcare; pharma may outperform Nifty: Sukhani

Sudarshan Sukhani of s2analytics.com recommends buying Cadila Healthcare and feels that pharma may outperform Nifty.
 Money Control2 months ago Sell Arvind, Cadila Healthcare: Sudarshan Sukhani  Moneycontrol.com1 week ago See upside in Sun Pharma: Sudarshan Sukhani  Moneycontrol.com2 months ago

Moberg Pharma signs development and licensing agreement with Cadila Pharmaceuticals for BUPI

Swedish pharmaceutical company Moberg Pharma AB (OMX: MOB) announced on Tuesday that it has entered into a development and license agreement with Cadila Pharmaceuticals Limited, a large healthcare manufacturing group in India, for BUPI, a novel ...
 Bloomberg1 month ago Cadila Pharma & Moberg Pharma enter development and license agreement for BUPI  PharmaBiz1 month ago Moberg and Cadila agree development and marketing deal for bupivacaine  Manufacturing Chemist1 month ago
United News of India

Zydus gets USFDA nod for Carboplatin injection

1:58PM Share Mumbai, Apr 1 (UNI) Pharma major, Zydus Cadila has received the final approval from the USFDA to market Carboplatin Injection, 10 mg/ml in 5 ml, 15 ml and 45 ml. The group now has more than 100 approvals and has so far filed ...
 United News of India3 weeks ago PHARMA-ZYDUS CADILA-APPROVAL  United News of India1 month ago
CPhI.cn

Moberg Pharma, Cadila sign deal for late-stage development of BUPI

Moberg Pharma and Cadila Pharmaceuticals have signed an agreement for late-stage development and commercialization of BUPI, a novel lozenge formulation of bupivacaine for pain management in oral mucositis patients. Under the development and license ...
 Pharmaceutical Business Review1 month ago Moberg Pharma partners with Cadila Pharmaceuticals for late-stage development and commercialisation of BUPI for oral mucositis  Bloomberg1 month ago BRIEF-Moberg Pharma and Cadila in agreement for late-stage development of BUPI  Reuters UK1 month ago Moberg Pharma AB (Formerly known as Moberg Derma) And Cadila Pharmaceuticals Enters Agreement For Late-Stage Development And Commercialization Of BUPI  BioSpace1 month ago
[x]  

Cadila Healthcare: The right remedy - Buy

The stock of pharma major Cadila Healthcare has corrected by over 20 per cent in the last five months. This was largely due to regulatory action by the US Food and Drug Administration (FDA) at two of its plants. In December 2015, the US FDA issued ...
 Hindu Business Line1 month ago 106 stocks trade ex-dividend  Smart Investor1 month ago Over hundred stocks trade ex-dividend  Business Standard India1 month ago
India Infoline

Zydus gets final USFDA nod for anti-diabetic Glyburide, Metformin

Pharma major Cadila Healthcare Ltd (Zydus Cadila) on Tuesday said it has received final approval from the United States Food and Drug Administration (USFDA) to market anti-diabetic drugs called ...
 Business Line1 month ago Zydus receives FDA final nod for anti-diabetic drug and other Top Corporate News  India Infoline1 month ago Cadila Pharma jumps 3% on Zydus receiving final FDA nod for anti-diabetic drug  India Infoline1 month ago

Prefer Cadila Over Lupin, Sun Pharma: Jai Bala

|Duration: 4 min, 16 sec Jai Bala of Cashthechaos.com says he believes focus should be on second rank pharma stocks like Cadila than front line names like Lupin and Sun Pharma. Second rank pharma companies are more likely to outperform the bigger ...
 NDTV4 weeks ago Look at Cadila Healthcare, Dishman Pharma: Jai Bala  Money Control2 months ago
Financial Express

Stocks in news: Tata Steel, Sharp India, Brigade, Cadila, Hero

Tata Steel | Sharp India | Brigade Enterprises | Kansai Nerolac | Cadila Healthcare | NHPC | Natco Pharma | Jain Irrigation | GVK Power | Ashok Leyland | Vakrangee | Gallant | Hero Motocorp | Mercator | Tata Communications and Nestle India are stocks, which ...
 Money Control4 weeks ago Seven stocks that remained in news today: Tata Steel, HealthCare Global and more  Financial Express4 weeks ago Thirteen buzzing stocks in today's trade: Finolex Cables, HealthCare Global, Adani Transmission and more  Financial Express4 weeks ago
India Infoline

Aurobindo Pharma gets ANDA approval and other Top Corporate News of the day

Cadila Healthcare said that it has received the final approval from the US drug regulator to market an anti-viral drug Acyclovir capsules (200 mg). (BS) Ashok Leyland has won orders valued at Rs8bn from the Indian armed forces. The company will ...
 India Infoline4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less